
Home / What’s new?
News & publications
Stay updated on the most recent developments in Symeres
Latest news

Amino acid synthesis at Symeres
The biocatalysis toolbox at Symeres enables efficient access to a wide range of multifunctional, optically pure, unnatural amino acids and their derivatives.

Peptidomimetics at Symeres
Macrocyclization of linear peptides is shown to be an effective way to overcome some of the shortcomings of peptide-based drug leads

π-Facial selectivity in the Diels–Alder reaction of glucosamine-based chiral furans and maleimides
Accessing novel chemical space by using carbohydrates as sustainable chiral starting materials for library synthesis.

Lipid chemistry at Symeres
Symeres has been supporting the global pharma and biotech industry with the synthesis and (ultra)-purification of these novel lipids. With the acquisition of Organix, we have significantly potentiated the platform.
Latest publications
Rapid deracemization through solvent cycling: proof-of-concept using a racemizable conglomerate clopidogrel precursor
Article:
Chem Comm, xxx
Chem Comm, xxx
The Tankyrase Inhibitor OM-153 Demonstrates Antitumor Efficacy and a Therapeutic Window ] in Mouse Models
Article:
Cancer Research Communications (2022) 2 (4): 233–245.
Cancer Research Communications (2022) 2 (4): 233–245.
Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020 (Oncolines publication)
Article:
Front. Oncol., Sec. Cancer Molecular Targets and Therapeutics 12 – 2022
Front. Oncol., Sec. Cancer Molecular Targets and Therapeutics 12 – 2022